CMP-DEPENDENT SIALIDASE ACTIVITY

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20170298405A1
SERIAL NO

15629040

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure is directed to the properties of certain glycosyltransferase variants having N-terminal truncation deletions or internal deletions. Any of the mutants disclosed in here exhibit α-2,6-sialyltransferase enzymatic activity in the presence of CMP-activated sialic acid as co-substrate, and in the presence of a suitable acceptor site. A fundamental finding documented in the present disclosure is that suchs enzyme are not only capable of catalyzing transfer of a sialidyl moiety but they are also capable of catalyzing hydrolytic cleavage of terminally bound sialic acid from a glycan.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ROCHE DIAGNOSTICS OPERATIONS INC9115 HAGUE ROAD INDIANAPOLIS IN 46250

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Greif, Michael Penzberg, DE 15 119
Malik, Sebastian Antdorf, DE 11 15
Sobek, Harald Biberach, DE 31 400
Thomann, Marco Penzberg, DE 13 15

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation